ALI HEALTH's stock surged 5.21% during intraday trading on Wednesday, marking a significant upward movement for the healthcare e-commerce company.

The sharp rise follows the company's announcement that it will seek shareholder approval to authorize a repurchase of up to 10% of its issued shares, alongside the declaration of a final and special dividend. These moves are seen as strong signals of commitment to shareholder returns.

Fundamental support for the rally comes from the company's recently reported fiscal year results, which showed revenue of RMB 34.255 billion and a net profit that surged 35.2% year-over-year. The positive sentiment was further bolstered by a broad sector rally, with its parent company and key peers in the medical e-commerce space also posting gains.